187 related articles for article (PubMed ID: 26981635)
1. Sialyltransferase and Neuraminidase Levels/Ratios and Sialic Acid Levels in Peripheral Blood B Cells Correlate with Measures of Disease Activity in Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis: A Pilot Study.
Liou LB; Huang CC
PLoS One; 2016; 11(3):e0151669. PubMed ID: 26981635
[TBL] [Abstract][Full Text] [Related]
2. α-2,3-Sialyltransferase 1 and neuraminidase-3 from monocytes in patients with rheumatoid arthritis correlate with disease activity measures: A pilot study.
Liou LB; Jang SS
J Chin Med Assoc; 2019 Mar; 82(3):179-185. PubMed ID: 30913115
[TBL] [Abstract][Full Text] [Related]
3. α-2,6-sialic acid/IgG anti-dsDNA ratios correlate with human lupus disease activity and possible mechanisms: A pilot study.
Liou LB; Wang TY; Liu IJ; Wu HC; Ke PY; Fang YF; Chen YF
Lupus; 2022 Jul; 31(8):927-938. PubMed ID: 35531921
[TBL] [Abstract][Full Text] [Related]
4. Predictors of Remission or Combined Remission and Low Disease Activity in Rheumatoid Arthritis Patients in Taiwan: A Prospective Cohort Study.
Tsai PH; Fang YF; Chen YF; Chen CC; Chiang WY; Chang CT; Huang YJ; Liou LB
J Clin Med; 2024 Apr; 13(9):. PubMed ID: 38731049
[No Abstract] [Full Text] [Related]
5. Serum free light chains as biomarkers for systemic lupus erythematosus disease activity.
Aggarwal R; Sequeira W; Kokebie R; Mikolaitis RA; Fogg L; Finnegan A; Plaas A; Block JA; Jolly M
Arthritis Care Res (Hoboken); 2011 Jun; 63(6):891-8. PubMed ID: 21312346
[TBL] [Abstract][Full Text] [Related]
6. Sialic-Acid-Related Enzymes of B Cells and Monocytes as Novel Markers to Discriminate Improvement Categories and to Fulfill Two Remission Definitions in Rheumatoid Arthritis.
Liou LB; Tsai PH; Fang YF; Chen YF; Chen CC; Lai JH
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629178
[TBL] [Abstract][Full Text] [Related]
7. B-lymphocyte activating factor in systemic lupus erythematosus and rheumatoid arthritis in relation to autoantibody levels, disease measures and time.
Becker-Merok A; Nikolaisen C; Nossent HC
Lupus; 2006; 15(9):570-6. PubMed ID: 17080911
[TBL] [Abstract][Full Text] [Related]
8. The value of decreased plasma gelsolin levels in patients with systemic lupus erythematosus and rheumatoid arthritis in diagnosis and disease activity evaluation.
Hu Y; Li H; Li WH; Meng HX; Fan YZ; Li WJ; Ji YT; Zhao H; Zhang L; Jin XM; Zhang FM
Lupus; 2013 Dec; 22(14):1455-61. PubMed ID: 24122723
[TBL] [Abstract][Full Text] [Related]
9. Associations of the Levels of C4d-bearing Reticulocytes and High-avidity Anti-dsDNA Antibodies with Disease Activity in Systemic Lupus Erythematosus.
Mora C; Medina-Rosas J; Santos AM; Jaimes DA; Arbeláez AM; Romero C; Cortes A; Londono J
J Rheumatol; 2016 Sep; 43(9):1657-64. PubMed ID: 27134246
[TBL] [Abstract][Full Text] [Related]
10. The relationship between serum ferritin levels and disease activity in systemic lupus erythematosus.
Beyan E; Beyan C; Demirezer A; Ertuğrul E; Uzuner A
Scand J Rheumatol; 2003; 32(4):225-8. PubMed ID: 14626629
[TBL] [Abstract][Full Text] [Related]
11. Serum ferritin level correlates with SLEDAI scores and renal involvement in SLE.
Tripathy R; Panda AK; Das BK
Lupus; 2015 Jan; 24(1):82-9. PubMed ID: 25253568
[TBL] [Abstract][Full Text] [Related]
12. Two systemic lupus erythematosus (SLE) global disease activity indexes--the SLE Disease Activity Index and the Systemic Lupus Activity Measure--demonstrate different correlations with activation of peripheral blood CD4+ T cells.
Daca A; Czuszyńska Z; Smoleńska Z; Zdrojewski Z; Witkowski JM; Bryl E
Hum Immunol; 2011 Dec; 72(12):1160-7. PubMed ID: 21906646
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies to box A of high mobility group box 1 in systemic lupus erythematosus.
Schaper F; de Leeuw K; Horst G; Maas F; Bootsma H; Heeringa P; Limburg PC; Westra J
Clin Exp Immunol; 2017 Jun; 188(3):412-419. PubMed ID: 28245520
[TBL] [Abstract][Full Text] [Related]
14. Increased circulating CXCL13 levels in systemic lupus erythematosus and rheumatoid arthritis: a meta-analysis.
Bao YQ; Wang JP; Dai ZW; Mao YM; Wu J; Guo HS; Xia YR; Ye DQ
Clin Rheumatol; 2020 Jan; 39(1):281-290. PubMed ID: 31523787
[TBL] [Abstract][Full Text] [Related]
15. Increased soluble CD72 in systemic lupus erythematosus is in association with disease activity and lupus nephritis.
Vadasz Z; Goldeberg Y; Halasz K; Rosner I; Valesini G; Conti F; Perricone C; Sthoeger Z; Bezalel SR; Tzioufas AG; Levin NA; Shoenfeld Y; Toubi E
Clin Immunol; 2016 Mar; 164():114-8. PubMed ID: 26883681
[TBL] [Abstract][Full Text] [Related]
16. CD69 to CD3 ratio of peripheral blood mononuclear cells as a marker to monitor systemic lupus erythematosus disease activity.
Su CC; Shau WY; Wang CR; Chuang CY; Chen CY
Lupus; 1997; 6(5):449-54. PubMed ID: 9229364
[TBL] [Abstract][Full Text] [Related]
17. Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus.
Petri M; Stohl W; Chatham W; McCune WJ; Chevrier M; Ryel J; Recta V; Zhong J; Freimuth W
Arthritis Rheum; 2008 Aug; 58(8):2453-9. PubMed ID: 18668552
[TBL] [Abstract][Full Text] [Related]
18. Identification of immune subsets with distinct lectin binding signatures using multi-parameter flow cytometry: correlations with disease activity in systemic lupus erythematosus.
Szabó E; Faragó A; Bodor G; Gémes N; Puskás LG; Kovács L; Szebeni GJ
Front Immunol; 2024; 15():1380481. PubMed ID: 38774868
[TBL] [Abstract][Full Text] [Related]
19. Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis.
Hepburn AL; Mason JC; Davies KA
Rheumatology (Oxford); 2004 May; 43(5):547-54. PubMed ID: 14747618
[TBL] [Abstract][Full Text] [Related]
20. Erythrocyte sedimentation rate and C-reactive protein levels are poorly correlated with clinical measures of disease activity in rheumatoid arthritis, systemic lupus erythematosus and osteoarthritis patients.
Keenan RT; Swearingen CJ; Yazici Y
Clin Exp Rheumatol; 2008; 26(5):814-9. PubMed ID: 19032813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
